Binding of copper and zinc by the antitumour agent L-alanosine.
D000409:Alanine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D002614:Chelating Agents; D003300:Copper / Q000378:metabolism*; D006801:Humans; D007928:Lethal Dose 50; D007941:Leukemia P388 / Q000188:drug therapy; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D009602:Nitrosamines / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D013482:Superoxide Dismutase / Q000378:metabolism; D015032:Zinc / Q000378:metabolism*
D002614:Chelating Agents; D009602:Nitrosamines; C000082:alanosine; D003300:Copper; D013482:Superoxide Dismutase; D015032:Zinc; D000409:Alanine